ArticleWorld journal of gastroenterology2025
Chemotherapy plus bevacizumab with or without anti-programmed death 1 immunotherapy as the second-line therapy in colorectal cancer.
Zhao Gao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.